SCHEMBL24201658

SCHEMBL24201658

C/C=N\c1c(C)ncnc1N1CCc2cc(C)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 2/20 0.41
KDM4E B2RXH2 6/20 0.39
MAPT P10636 5/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 2/20 0.39
RXFP1 Q9HBX9 1/20 0.39
EIF4E P06730 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
NOTUM Q6P988 1/20 0.36
EGFR P00533 4/20 0.36
ALDH1A1 P00352 4/20 0.36
CSF1R P07333 2/20 0.35
GPR119 Q8TDV5 2/20 0.35
PDGFRB P09619 3/20 0.34
KDR P35968 3/20 0.34
TUBB4A P04350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24201877 0.85 EGFR (0.47) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL23761414 0.81 SRD5A1 (0.45) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL24202017 0.76 NOTUM (0.41) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL23761530 0.75 NOTUM (0.40) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL24202118 0.74 MKNK1 (0.42) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL23761495 0.72 MKNK1 (0.55) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL24202076 0.70 MKNK1 (0.34) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL23761642 0.70 EIF4E (0.35) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL24201722 0.69 EIF4E (0.47) SRD5A1KDM4EMAPTSMN1; SMN2NPC1
SCHEMBL8652258 0.68 EGFR (0.75) EGFRCSF1RPDGFRBKDRTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939981-A1 FUSED THIAZOLOPYRIMIDINE DERIVATIVES AS MNKS INHIBITORS LifeArc (GB) 2022-01-19 EP disclosed